News from eli lilly and company A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NYSE:LLY)

Feb 03, 2016, 12:30 ET
Eli Lilly and Company logo.

American Diabetes Association® Survey Shows Summer Camp Can Positively Impact Children's Disease Management Skills, Confidence and Stress

A three-year survey by the American Diabetes Association (Association) shows attending summer camp can do much more than lift the spirits of...

Jan 28, 2016, 06:25 ET
Eli Lilly and Company logo.

Lilly Reports Fourth-Quarter and Full-Year 2015 Results

 Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2015. $ in...

Jan 27, 2016, 14:00 ET
Eli Lilly and Company logo.

Lilly To Present At Leerink Partners Global Healthcare Conference

 Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Wednesday, February 10, 2016. Derica...

Jan 27, 2016, 09:00 ET
Eli Lilly and Company logo.

Lilly and Roche Diagnostics to Collaborate on Alzheimer's Disease Adjunct Diagnostic Tool

Eli Lilly and Company (NYSE: LLY) today announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially...

Jan 25, 2016, 08:30 ET
Eli Lilly and Company logo.

U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)

The U.S. Food and Drug Administration (FDA) accepted a supplemental New Drug Application for Jardiance® (empagliflozin) based on...

Jan 21, 2016, 10:00 ET
Humulin(R) R U-500 KwikPen(R)

U.S. Food and Drug Administration Approves Humulin® R U-500 KwikPen®

 The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin® R U-500 KwikPen®(insulin human...

Jan 19, 2016, 08:00 ET
Eli Lilly and Company logo.

Lilly and Incyte Announce Submission of New Drug Application to FDA for Oral Once-Daily Baricitinib for Treatment of Moderate-to-Severe Rheumatoid Arthritis

 Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced that Lilly has submitted a new drug application (NDA)...

Jan 05, 2016, 06:45 ET
Eli Lilly and Company logo

Lilly Announces 2016 Financial Guidance, Updates 2015 Expectations

 Eli Lilly and Company (NYSE: LLY) today announced its 2016 financial guidance and highlighted key events for the upcoming year. The company...

Jan 04, 2016, 10:00 ET
Eli Lilly and Company logo

Lilly to Present at J.P. Morgan Healthcare Conference

Eli Lilly and Company (NYSE: LLY) will present at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016. John C....

Dec 16, 2015, 19:18 ET
Eli Lilly and Company logo.

FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment

Eli Lilly and Company (NYSE: LLY) and Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration...

Dec 15, 2015, 15:00 ET
Eli Lilly and Company logo

Lilly Sets Dates and Conference Calls for 2016 Financial Guidance and Fourth-Quarter 2015 Financial Results

 Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2016 on Tuesday, January 5, 2016 and, separately, will announce its...

Dec 15, 2015, 07:00 ET
Eli Lilly and Company logo

Juan R. Luciano elected to Lilly board of directors

 The board of directors of Eli Lilly and Company (NYSE: LLY) has elected Juan R. Luciano as a new member, effective February 1, 2016. Luciano...

Dec 10, 2015, 06:30 ET
Eli Lilly and Company logo.

Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA® Combination Trial

Eli Lilly and Company (NYSE: LLY) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced another immuno-oncology...

Dec 08, 2015, 07:15 ET
Eli Lilly and Company logo.

Lilly Announces Dividend Increase

The board of directors of Eli Lilly and Company (NYSE: LLY) today announced a 2 percent increase in its quarterly dividend. The dividend for the...

Dec 04, 2015, 08:00 ET
Eli Lilly and Company logo

Lilly Ends Basal Insulin Peglispro Development Program

 Eli Lilly and Company (NYSE: LLY) today announced that it will cease development of basal insulin peglispro (BIL), a potential treatment for...

Dec 01, 2015, 13:00 ET
Eli Lilly and Company logo

New Data Show Lilly's Once-Weekly Trulicity® (dulaglutide) is Effective as Add-on Treatment to Sulfonylurea

 New data from a completed Phase 3 trial show Trulicity® (dulaglutide) 1.5 mg plus a sulfonylurea was significantly more effective than a...

Nov 24, 2015, 14:41 ET
Eli Lilly and Company logo.

FDA Approves Portrazza™ (necitumumab) for Specific Type of Lung Cancer

  Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Portrazza™ (necitumumab...

Nov 20, 2015, 10:00 ET
Eli Lilly and Company logo

Lilly to Provide Detailed Review of Elanco Animal Health and Alzheimer's R&D Strategy at Investment Community Meeting

 Eli Lilly and Company (NYSE: LLY) today announced it will host a meeting for the investment community, including institutional investors,...

Nov 19, 2015, 06:30 ET
Eli Lilly and Company logo

Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial

 Eli Lilly and Company (NYSE: LLY) and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the extension of...

Nov 09, 2015, 10:45 ET
Eli Lilly and Company logo

New Jardiance® (empagliflozin) data show improved CV outcomes regardless of heart failure status at baseline

 New sub-analysis data presented today showed the reduction in risk for hospitalization for heart failure or cardiovascular death with...